Allergy Testing
FeNO Testing
Fractional exhaled nitric oxide (FeNO) measures airway inflammation — guides asthma diagnosis and biologic therapy selection.
What This Test Evaluates
- Eosinophilic airway inflammation
- Asthma phenotype (eosinophilic vs. non-eosinophilic)
- Response to inhaled corticosteroids
- Biologic therapy eligibility
- Adherence to controller medication
Who May Need This Test
- Patients with suspected asthma
- Patients with unclear asthma phenotype
- Patients being evaluated for biologic therapy
- Patients with poor response to ICS
- Patients with suspected non-adherence
Preparation Requirements
- Avoid eating for 1 hour before test
- Avoid caffeine and alcohol before test
- No smoking for at least 1 hour
- Inform of all medications
Procedure
- Breathe out steadily into FeNO analyzer
- Measures nitric oxide concentration in exhaled breath
- Results in parts per billion (ppb)
- Takes ~5 minutes
Interpretation
- Elevated FeNO (>50 ppb adults, >35 children) suggests eosinophilic inflammation
- Supports asthma diagnosis and ICS responsiveness
- Guides biologic therapy selection (anti-IL5 for high FeNO)
- Declining FeNO suggests treatment response
- Low FeNO suggests non-eosinophilic phenotype
Limitations
- Elevated in non-asthma conditions (rhinitis, infection)
- Affected by smoking, diet and medications
- Cannot diagnose asthma alone
- Does not identify specific triggers
Follow-Up
- Guide biologic therapy selection
- Monitor treatment response
- Assess adherence
- Adjust controller therapy
Related Pages
Ready to get answers?
Book a specialist consultation to discuss your symptoms and treatment options.
Medical disclaimer: This page is for educational purposes and does not constitute medical advice. Individual diagnosis and treatment require consultation with a qualified healthcare professional. If you are experiencing a medical emergency, seek immediate care.